I'm the Co-Founder of Pharma Expanse (PE), the long-term, exclusive, Business Development partner for Fareva (20+ months) and CiVentiChem (18+ months). I was also previously employed by Fareva for 10.5 years, serving as Head of US BD and VP Global BD. I'm interested to meet with Executives and Consultants that outsource development and manufacturing to CDMOs. Fareva Capabilities: Drug Substance • Locations: 3 plants in France and Germany • Key Technologies: Highly potent APIs, hormones (dedicated lines), sterile crystallization, spray drying, micronization milling, high pressure hydrogenation, cryogenic. • GMP Scale: 10L to 10,000L (OEB1 to 6) Drug Product • Locations: 15 plants (France, Germany, Italy, Austria, USA, Colombia) • Key Technologies: Oral Solid Dose, Sterile Fill Finish, Semi-solids, Ophthalmic, supporting both conventional and high-potent therapeutics. • Modalities: small molecules, ADCs, Peptides, biologics, nucleic acids CiVentiChem Capabilities: • Location: 2 plants in India • Key Technologies: RSM development and manufacturing for clinical development and commercial programs, including FTEs for process research and medicinal chemistry